Study Summary
This trial will test if a new therapy can help people with prediabetes.
Eligible Conditions
- Prediabetes
Treatment Effectiveness
Effectiveness Progress
Study Objectives
2 Primary · 3 Secondary · Reporting Duration: Change from baseline to 3-month follow-up and 6-month follow-up
Change from baseline to 3-month follow-up and 6-month follow-up
Body mass index
C-peptide
HbA1c
Health behavior
Perceived Stress Scale
Trial Safety
Safety Progress
Trial Design
1 Treatment Group
Modified EAET for Prediabetes
1 of 1
Experimental Treatment
16 Total Participants · 1 Treatment Group
Primary Treatment: Modified EAET for prediabetes · No Placebo Group · N/A
Modified EAET for Prediabetes
Behavioral
Experimental Group · 1 Intervention: Modified EAET for prediabetes · Intervention Types: BehavioralTreatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Modified EAET for prediabetes
2022
N/A
~20
Trial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: change from baseline to 3-month follow-up and 6-month follow-up
Who is running the clinical trial?
Wayne State UniversityLead Sponsor
288 Previous Clinical Trials
104,625 Total Patients Enrolled
Eligibility Criteria
Age 18+ · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:You have a HbA1C value of 5.7% to 6.4%.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Conditions
Cancer Related
Treatments